373110.KQ
Xcell Therapeutics, Inc.
KOE · Healthcare · Biotechnology · KR
KRW 998.00
−4.04%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.21x
- Price / sales
- 3.18x
- Price / cash flow
- -1.35x
Enterprise value
- Enterprise value
- KRW 15.0B
- EV / sales
- 3.45x
- EV / EBITDA
- -1.54x
- EV / EBIT
- -1.36x
- Market cap
- KRW 13.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026